|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-9-7
|
|
pubmed:abstractText |
The aim of this study was to assess the efficacy and safety of the once-daily atomoxetine compared with placebo in pediatric patients with attention-deficit/hyperactivity disorder (ADHD) in Taiwan.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1044-5463
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
447-60
|
|
pubmed:meshHeading |
pubmed-meshheading:17822340-Adolescent,
pubmed-meshheading:17822340-Adrenergic Uptake Inhibitors,
pubmed-meshheading:17822340-Appetite,
pubmed-meshheading:17822340-Attention Deficit Disorder with Hyperactivity,
pubmed-meshheading:17822340-Child,
pubmed-meshheading:17822340-Double-Blind Method,
pubmed-meshheading:17822340-Drug Administration Schedule,
pubmed-meshheading:17822340-Faculty,
pubmed-meshheading:17822340-Female,
pubmed-meshheading:17822340-Humans,
pubmed-meshheading:17822340-Male,
pubmed-meshheading:17822340-Nausea,
pubmed-meshheading:17822340-Parents,
pubmed-meshheading:17822340-Propylamines,
pubmed-meshheading:17822340-Psychiatric Status Rating Scales,
pubmed-meshheading:17822340-Severity of Illness Index,
pubmed-meshheading:17822340-Taiwan,
pubmed-meshheading:17822340-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder.
|
|
pubmed:affiliation |
Department of Psychiatry, College of Medicine, National Taiwan Universiy, Taipei, Taiwan.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
